References
- Screening for fetal chromosome abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217–28
- Wilson JG, Jungner G. Principles and practice of screening for disease. Public Health Paper No. 34. Geneva: World Health Organization; 1968
- Malone FD, Canick JA, Ball RH, et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 2005;353:2001–11
- Lutgendorf MA, Stoll KS, Knutzen DM, Foglia LM. Noninvasive prenatal testing: limitations and unanswered questions. Genet Med 2013;16:281–5
- Snijders RJ, Sundberg K, Holzgreve W, et al. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13:167–70
- Manri AK, Bhatia G, Strymish J, et al. Medicine’s uncomfortable relationship with math: calculating positive predictive value. JAMA Intern Med 2014;174:991–3
- Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014;211:527.e1–17
- Relman AS. The new medical–industrial complex. NEJM 1980;303:963–70